Inventor · disambiguated record
Vladimir Gabai
Also filed as: GABAI VLADIMIR
3 granted patents·7 pending applications·15 citations·filing 1998–2024
62Inventor score
Files withCURELAB ONCOLOGY INC4PUBLIC JOINT STOCK COMPANY SCIENT INDUSTRIAL CENTRE BORSHCHAHIVSKIY CHEMICA1PUBLIC JOINT STOCK COMPANY SCIENT INDUSTRIAL CENTRE BORSHCHAHIVSKIY CHEMICAL PHARMACEUTICAL P1PUBLIC JOINT STOCK COMPANY SCIENT INDUSTRIAL CENTRE BORSHCHAHIVSKIY CHEMICAL PHARMACEUTICAL PL1PUBLIC JOINT STOCK COMPANY “SCIENTIFIC IND CENTRE BORSHCHAHIVSKIY CHEMICAL PHARMACEUTICAL PLA1
Top patents by PatentIndex Score
10 records- 0169US11098098B2Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseasesCURELAB ONCOLOGY INC·Filed 2018·Granted Aug 24, 2021·1 cites·6 claims
- 0258US2022009985A1Methods and Compositions Relating to p62/SQSTM1 for the Treatment and Prevention of Inflammation-Associated DiseasesCURELAB ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 0356US2025332186A1Methods and Compositions Relating to p62/SQSTM1 for the Treatment and Prevention of Inflammation-Associated DiseasesCURELAB ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 0455US2022074958A1Methods of monitoring safety of quercetin compositionsPUBLIC JOINT STOCK COMPANY SCIENT INDUSTRIAL CENTRE BORSHCHAHIVSKIY CHEMICA·Filed 2021·Application pending·0 cites
- 0552US11156623B2Methods of monitoring safety of quercetin compositionsPUBLIC JOINT STOCK COMPANY “SCIENTIFIC IND CENTRE BORSHCHAHIVSKIY CHEMICAL PHARMACEUTICAL PLA·Filed 2018·Granted Oct 26, 2021·0 cites·19 claims
- 0647US2021220437A1Compositions and Methods Relating to p62 for the Treatment and Prophylaxis of Age-Related Macular DegenerationCURELAB ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 0747US2016324944A1Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseasesVENANZI FRANCO·Filed 2014·Application pending·0 cites
- 0843US6096711AHsp72 induction and applicationsFiled 1998·Granted Aug 1, 2000·14 cites·21 claims
- 0936US2020197355A1Methods, compositions and containers for reducing solid form quercetin degradation and 2-(3,4-dihydroxybenzoyloxy)-4,6-dihydroxybenzoic acid toxic byproducts thereofPUBLIC JOINT STOCK COMPANY SCIENT INDUSTRIAL CENTRE BORSHCHAHIVSKIY CHEMICAL PHARMACEUTICAL PL·Filed 2018·Application pending·0 cites
- 1036US2020197354A1Methods, compositions and containers for reducing solid form quercetin degradation and 2,4,6-trihydroxybenzoic acid toxic byproduct thereofPUBLIC JOINT STOCK COMPANY SCIENT INDUSTRIAL CENTRE BORSHCHAHIVSKIY CHEMICAL PHARMACEUTICAL P·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vladimir Gabai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →